Literature DB >> 19108222

The difference in behaviour of basophil leucocytes and mast cells towards compound 48/80.

K R Haye, R Schneider.   

Abstract

Year:  1966        PMID: 19108222      PMCID: PMC1510878          DOI: 10.1111/j.1476-5381.1966.tb01895.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  15 in total

1.  New serological test for allergy in man.

Authors:  W B SHELLEY
Journal:  Nature       Date:  1962-09-22       Impact factor: 49.962

2.  In vitro effect of licithinase A on the cytology of the human basophil.

Authors:  W B SHELLEY; L JUHLIN
Journal:  J Lab Clin Med       Date:  1962-10

3.  Mast cells and anaphylaxis.

Authors:  I MOTA
Journal:  Ann N Y Acad Sci       Date:  1963-02-26       Impact factor: 5.691

4.  Histidine decarboxylase activity of basophils from chronic myelogenous leukemic patients. Origin of blood histamine.

Authors:  W J HARTMAN; W G CLARK; S D CYR
Journal:  Proc Soc Exp Biol Med       Date:  1961-05

5.  Mast cells in bronchial connective tissue of man: their modifications in asthma and after treatment with the histamine liberator 48/80.

Authors:  G SALVATO
Journal:  Int Arch Allergy Appl Immunol       Date:  1961

6.  Skin reactions to compound 48/80 in normal subjects and patients with urticaria and eczema.

Authors:  L JUHLIN; C RUNE
Journal:  Acta Derm Venereol       Date:  1962       Impact factor: 4.437

7.  Histamine-liberator 48/80 and basophilic leukocytes.

Authors:  B H MARKS; R SORGEN; H GINSBURG
Journal:  Biochem Pharmacol       Date:  1959-09       Impact factor: 5.858

8.  Histamine formation in human blood.

Authors:  S E LINDELL; H RORSMAN; H WESTLING
Journal:  Acta Allergol       Date:  1961

9.  The effect of compound 48/80 on the rat mast cell.

Authors:  G I Horsfield
Journal:  J Pathol Bacteriol       Date:  1965-10

10.  Cytological and pharmacological observations on the release of histamine by mast cells.

Authors:  D W FAWCETT
Journal:  J Exp Med       Date:  1954-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.